{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifgxc3kc5gy5oe7cwbykwq2iiocgdsujatzuiqlm7tkldii2rirci",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnunuhnuwkw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidpwyyptpzvrqkr6pnvdkixz2xmil3lqncekwqixkhnnemrlxzsba"
    },
    "mimeType": "image/jpeg",
    "size": 812858
  },
  "path": "/news/2026-06-therapy-reverse-autism-brain-deficits.html",
  "publishedAt": "2026-06-09T11:20:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers have identified a promising new therapeutic strategy for autism spectrum disorder (ASD). A research team led by Director KIM Eunjoon of the IBS Center for Synaptic Brain Dysfunctions has now identified a promising new strategy for restoring NMDA receptor (NMDAR) function by targeting a glycine transporter called Slc6a20a/SLC6A20.",
  "title": "Novel therapy may reverse autism-related brain deficits, study suggests"
}